[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100461106":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":24,"responsibleParty":41,"collaborators":7,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":54,"maxAge":7,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"First Affiliated Hospital of Fujian Medical University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Antibiotics treatment","After receiving intravenous antibiotics treatment for 2 weeks, and clinician determines whether to continue with any antibiotics.",[14],{"name":15,"affiliation":5,"role":16},"Zhang, Director","STUDY_DIRECTOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},"Fang","CONTACT","18084768503","86","9738006@qq.com",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":7,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"The First Affiliated Hospital of Fujian Medical University","RECRUITING","Fuzhou","Fujian","China","CN",{"type":33,"coordinates":34},"Point",[35,36],119.30611,26.06139,{"lat":36,"lon":35},[39],{"name":40,"role":20,"phone":7,"phoneExt":7,"email":23},"Fang, Vice directors",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Xinyu Fang","Deputy chief physician","100461106","prospective-cohort-study-on-antibiotic-course-and-efficacy-after-two-stage-revision-in-pji-100461106",false,"NCT05284318","Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.","Effect of Antibiotic Treatment Course on Clinical Outcome After Two-stage Revision of Prosthetic Joint Infection: A Prospective Cohort Study.","PACER-PJI","Inclusion Criteria:\n\n\\- 1. A diagnosis of PJI was made according to MSIS criteria. 2. Received spacer implantation and a full course of antibiotic treatment (at least 6 weeks), the patient was clinically determined to have infection control and underwent secondary joint revision.\n\n3\\. Age ≥18 years old. 4. The patient voluntarily participated in the study, and was physically and mentally tolerant to the treatment process and various tests of the study. He has signed an informed consent form and passed the examination of all the hospital ethics committees participating in the study.\n\nExclusion Criteria:\n\n* 1\\. Follow-up data not available. 2. Researchers judge that patients no longer meet the standards of the study due to compliance problems","ALL","18 Years",{"count":56,"type":57},500,"ESTIMATED","2 Years","OBSERVATIONAL","This is a multicenter prospective cohort study in which patients were evaluated by inclusion and exclusion criteria before phase II revision surgery. Eligible patients will be included in this study after signing the informed consent form. After the second stage revision, according to the patient's symptoms and examination results, the attending physician used a reasonable antibiotic treatment scheme (including intravenous and oral medication). All patients voluntarily participated in the study and signed informed consent. During the treatment period, all prospective patients underwent clinical evaluation at the time points of 1, 3, 6, 12, 18 and 24 months after the start of antibiotic treatment after phase II revision. The infection control rate of patients was evaluated by follow-up at least 2 years after operation, so as to analyze the effect of antibiotic treatment course after two-stage revision of periprosthetic joint infection.",[62,63],"Periprosthetic Joint Infection","Anti-Bacterial Agents",[65,66,63],"Periprosthetic joint infection","Second-stage revision","2022-03-09",{"date":69,"type":70},"2022-03-17","ACTUAL",{"date":72,"type":70},"2021-12-01",{"date":74,"type":57},"2026-12-31",{"name":5,"class":6},1]